Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Katy Leung, MD, provides insight into the existing sex and gender differences between men and women with axial spondyloarthritis.
A significant number of cases of post-COVID-19 myocarditis have been reported.
Recommendations for clinicians regarding the treatment of skin infections in people who inject drugs was provided in an interview with Raja Sivamani, MD, MS, AP.
Drs Kronzer and Tatangelo discuss the major comorbidities of patients before and after the diagnosis of rheumatoid arthritis and how to manage these disorders.
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents. We spoke with Cécile Rousseau, MD, researcher, psychiatrist, and professor in the division of social and transcultural psychiatry at McGill University in Montreal, Canada about the impact of the COVID-19 pandemic on adolescent mental health.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
Drs Jeffrey A. Sparks and Vivian P. Bykerk join the ongoing debate about methotrexate as a potential risk factor for lung disease in rheumatoid arthritis and the current clinical implications.
Insufficient pain management during childhood immunizations may lead to increased fear of needles and later health care avoidance.
For patients with rheumatoid arthritis, studies show the benefits of certain dietary patterns and nutrients, including their possible protective effects on disease risk and progression.
